Literature DB >> 12466794

Prognostic value of perfusion-FDG mismatch in ischemic cardiomyopathy.

Jeroen J Bax1, Frans C Visser, Don Poldermans, Abdou Elhendy, Eric Boersma, Cees A Visser, Jos R T C Roelandt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12466794     DOI： 10.1067/mnc.2002.125218

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  3 in total

Review 1.  Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation.

Authors:  G A Beller
Journal:  J Nucl Cardiol       Date:  1997 Mar-Apr       Impact factor: 5.952

Review 2.  Prognostic utility of myocardial viability assessment.

Authors:  S Iskander; A E Iskandrian
Journal:  Am J Cardiol       Date:  1999-03-01       Impact factor: 2.778

3.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.

Authors:  F Haas; C J Haehnel; W Picker; S Nekolla; S Martinoff; H Meisner; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.